Clinical Trial Update: Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy

View source ↗

Summary

The trial update reports completion of a study evaluating quality-of-life outcomes in prostate cancer patients receiving adjuvant goserelin (Zoladex) therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: AstraZeneca | Conditions: Prostate Cancer | Status: COMPLETED